Oct 2026
A Nanodelivery Platform Harnessing Synthetic Lethality and Efferocytosis Inhibition for Synergistically Enhanced Immunotherapy of Triple-Negative Breast Cancer.
Findings indicate that precise molecularly targeted ICD combined with coordinated immune activation enables efficient primary tumor suppression and promotes T-cell phenotypes associated with antitumor immune memory, providing a novel paradigm for cancer immunotherapy.
Hua-Wei Liu, Sheng-Ming Wu, Han Zhou et al.
· Small · 0 citations